Skip to content
healthcare.dev

Everolimus

NDC 72319-015, everolimus, tablet, from i3 Pharmaceuticals, LLC.

Product NDC
72319-015
Status
Listed
Labeler
i3 Pharmaceuticals, LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA219464
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/72319-015 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • EVEROLIMUS.5 mg/1

Pharmacologic classes

Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; Decreased Immunologic Activity [PE]; Kinase Inhibitor [EPC]; Protein Kinase Inhibitors [MoA]; mTOR Inhibitor Immunosuppressant [EPC]; mTOR Inhibitors [MoA]

Package NDCNDC-11Package
72319-015-027231900150260 TABLET in 1 CONTAINER (72319-015-02)
72319-015-607231900156060 BLISTER PACK in 1 CARTON (72319-015-60) / 10 TABLET in 1 BLISTER PACK (72319-015-10)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/be5da0fd-8fd4-4f84-a307-f270048d503c

Use it

Look up 72319-015 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/72319-015 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 72319-015. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.